Shortage reports
Actual shortage:
37 (4%)
Anticipated shortage:
9 (1%)
Avoided shortage:
55 (6%)
Resolved:
772 (88%)
873
Discontinuation Reports
To be discontinued:
1 (1%)
Discontinued:
120 (98%)
Reversed:
1 (1%)
122
23 (2%)
9 (19%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DOCETAXEL INJECTION USP | 10MG | SOLUTION | Resolved | 2024-03-22 | 2024-04-26 | 223128 |
| DOCETAXEL INJECTION USP | 10MG | SOLUTION | Actual shortage | 2025-05-07 | 2025-05-20 | 256814 |
| DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2020-03-06 | 2020-03-27 | 107943 |
| DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2019-11-11 | 2019-12-17 | 98444 |
| DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2020-01-20 | 2020-03-05 | 103614 |
| DOCETAXEL INJECTION USP | 10.0MG | SOLUTION | Resolved | 2018-06-29 | 2018-08-23 | 53315 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-26 | 2018-12-21 | 67675 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-11-06 | 2018-11-22 | 66323 |
| DOSTINEX | 0.5MG | TABLET / TABLETTE | Resolved | 2017-03-13 | 2017-04-28 | 2039 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2024-09-25 | 2024-10-21 | 238507 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2019-10-09 | 2019-12-21 | 95815 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2019-01-25 | 2019-09-10 | 73569 |
| DOSTINEX | 0.5MG | TABLET | Resolved | 2018-03-05 | 2018-03-08 | 41789 |
| DOXORUBICIN | 2MG | SOLUTION | Resolved | 2023-07-26 | 2023-09-12 | 200032 |
| DOXORUBICIN | 2MG | SOLUTION | Resolved | 2018-02-21 | 2019-05-02 | 40515 |
| DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | 50MG | POWDER FOR SOLUTION | Resolved | 2023-07-20 | 2023-09-14 | 199246 |
| DUAVIVE | 0.45MG 20MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2020-05-13 | 2023-06-27 | 114978 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-05-30 | 2024-07-12 | 229180 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-07-25 | 2024-08-09 | 233656 |
| DUAVIVE | 20MG 0.45MG | TABLET (IMMEDIATE AND EXTENDED RELEASE) | Resolved | 2024-08-19 | 2025-01-23 | 235491 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALDACTAZIDE 25 | 25MG 25MG | TABLET | Discontinued | 2019-10-01 | 2020-04-13 | 95153 |
| ALDACTAZIDE 50 | 50MG 50MG | TABLET | Discontinued | 2019-10-01 | 2020-04-13 | 95156 |
| AMINOPHYLLINE INJECTION USP | 25MG | SOLUTION | Discontinued | 2019-02-28 | 2019-02-28 | 77145 |
| AMINOPHYLLINE INJECTION USP | 25MG | SOLUTION | Discontinued | 2023-05-19 | 2023-05-19 | 192828 |
| ARICEPT | 10MG | TABLET | Discontinued | 2019-10-01 | 2020-04-13 | 95141 |
| ARICEPT RDT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-14 | 2022-10-21 | 137468 |
| ARICEPT RDT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-04-14 | 2024-08-12 | 137465 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269826 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2026-03-13 | 269846 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269831 |
| ATIVAN | 0.5MG | TABLET | Discontinued | 2025-10-17 | 2026-03-13 | 269843 |
| ATIVAN | 1MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269837 |
| ATIVAN | 2MG | TABLET | Discontinued | 2025-10-17 | 2025-11-03 | 269840 |
| ATROPINE SULFATE INJECTION USP | 1MG | SOLUTION | Discontinued | 2025-08-18 | 2025-08-19 | 265488 |
| ATROPINE SULFATE INJECTION USP | 0.5MG | SOLUTION | Discontinued | 2021-09-07 | 2021-09-08 | 145250 |
| BACITRACIN USP | 50000UNIT | POWDER FOR SOLUTION | Discontinued | 2021-03-18 | 2021-04-01 | 135983 |
| CALCIUM CHLORIDE INJECTION USP | 100MG | SOLUTION | Discontinued | 2025-08-19 | 2025-08-19 | 265641 |
| CARDURA-1 TAB 1MG | 1MG | TABLET | Discontinued | 2018-03-29 | 2018-12-19 | 44235 |
| CARDURA-2 TAB 2MG | 2MG | TABLET | Discontinued | 2018-03-29 | 2018-12-19 | 44240 |
| CARDURA-4 TAB 4MG | 4MG | TABLET | Discontinued | 2018-03-29 | 2018-12-19 | 44245 |